Cargando...

Early Therapy Assessment of Combined Anti-DR5 Antibody and Carboplatin in Triple-Negative Breast Cancer Xenografts in Mice Using Diffusion-Weighted Imaging and (1)H MR Spectroscopy

PURPOSE: To assess the early response of triple-negative breast-cancer (TNBC) following TRA-8 and carboplatin therapy using DWI and MRS in 2LMP and SUM159 mouse models. MATERIALS AND METHODS: Four groups (n = 5/group) of each model were untreated or treated with carboplatin, TRA-8, and combination,...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhai, Guihua, Kim, Hyunki, Sarver, David, Samuel, Sharon, Whitworth, Lee, Umphrey, Heidi, Oelschlager, Denise K., Beasley, T. Mark, Zinn, Kurt R.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4076049/
https://ncbi.nlm.nih.gov/pubmed/24151215
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmri.24319
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!